Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Afluria vs Fluzone in Adults Aged 65 Years and Older
NCT00735475Phase 4Completed
- Sponsor
- CSL Seqirus
- Start
- Oct 2008
- Primary completion
- Jan 2009
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of standard dose influenza vaccine in influenza, sponsored by CSL Seqirus. Started Oct 2008; status: completed.
02
Drugs
standard dose influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00735475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735475.